SCHEMBL6329264

SCHEMBL6329264

CCN(Cc1ccccc1)CC1CC(c2ccc(N3CCCC3)cc2C)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.41
CNR2 P34972 2/20 0.38
CNR1 P21554 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
RORC P51449 1/20 0.37
PRMT6 Q96LA8 1/20 0.35
KDM4E B2RXH2 2/20 0.34
BCHE P06276 1/20 0.34
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
BLM P54132 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
AGXT P21549 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6329260 1.00 SIGMAR1 (0.41) SIGMAR1CNR2CNR1MEN1KMT2A
SCHEMBL6330742 0.79 HPGD (0.39) SIGMAR1MEN1KMT2APRMT6KDM4E
SCHEMBL6324501 0.76 MEN1 (0.34) SIGMAR1MEN1KMT2AUSP2ALDH1A1
SCHEMBL6324495 0.76 MEN1 (0.34) SIGMAR1MEN1KMT2AUSP2ALDH1A1
SCHEMBL6324367 0.74 HPGD (0.35) SIGMAR1MEN1KMT2APRMT6KDM4E
SCHEMBL6329232 0.74 GAA (0.49) SIGMAR1MEN1KMT2AKDM4EMAPT
SCHEMBL6329235 0.74 GAA (0.49) SIGMAR1MEN1KMT2AKDM4EMAPT
SCHEMBL5789492 0.71 HRH3 (0.54) MEN1KMT2AKDM4EALDH1A1
SCHEMBL5789495 0.71 HRH3 (0.54) MEN1KMT2AKDM4EALDH1A1
SCHEMBL6320500 0.69 HTR1A (0.32) MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171181-A1 3-Benzyloxymethyl-1-(4-pyrrolidin-1-ylmethyl-phenyl)-cyclobutanol for example; treating allergies and mood disorders; use in combination with a histamine H1 antagonist or a neurotransmitter re-uptake blocker PFIZER INC 2005-08-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171181-A1 3-Benzyloxymethyl-1-(4-pyrrolidin-1-ylmethyl-phenyl)-cyclobutanol for example; treating allergies and mood disorders; use in combination with a histamine H1 antagonist or a neurotransmitter re-uptake blocker HRH3, HRH4, HRH1 SIGMAR1 1261/4885CNR2 105/4885CNR1 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.